Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 692-721-8 | CAS number: 757251-39-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- other information
- Study period:
- Nov 2009 to Mar 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- no
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide
- EC Number:
- 692-721-8
- Cas Number:
- 757251-39-1
- Molecular formula:
- C13 H12 F N3 O2
- IUPAC Name:
- 4-(4-amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- Vehicle composition: 0.7 mL Polyethylenglycol + 0.05 mL Ethanol abs. + 0.25 mL Solutol HS15
- Details on exposure:
- - Application volume: 5 mL/kg bw
- Rationale for the selection of the starting dose:
In order to select an appropriate dose range, male and female rats were treated in a pre-experiment with BAY 74-2329 and observed over a period of three days from start of treatment. After a single oral treatment of three male and female rats with 2000 mg/kg BAY 74-2329, all three female animals died or were sacrificed in moribund state on the day after treatment. Following single oral treatment of 2 male and 2 female rats with 1000 mg/kg, one male and one female animal died on the day after treatment. Daily treatment (i.g.) of 2 male and 2 female rats with 500 mg/kg BAY 74-2329 over three days resulted in some clinical signs (atactic gait) in animals of both sex but was tolerated without mortality.
Based on the findings of the pre-experiment, 500 mg/kg BAY 74-2329 was chosen as the highest dose in the bone marrow Micronucleus test. Additionally, 250 and 125 mg/kg were chosen as mid and low dose. - Duration of treatment / exposure:
- 3 days
- Frequency of treatment:
- once daily
- Post exposure period:
- none
Doses / concentrations
- Remarks:
- Doses / Concentrations:
125, 250, 500 mg/kg
Basis:
actual ingested
- No. of animals per sex per dose:
- 6
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Ethyl methanesulfonate (200 mg/kg bw)
Examinations
- Tissues and cell types examined:
- micronuclei in rat bone marrow
- Details of tissue and slide preparation:
- The preparation and microscopic analysis of micronuclei in rat bone marrow was performed according the pertinent SOP, which complies with internationally accepted guidelines and recommendations. Bone marrow was collected from all animals after sacrifice on study day 3. The femurs were dissected out from each animal and the bone marrow was flushed/ aspirated into fetal calf serum. The resulting cell suspensions were filtered through a cellulose column, centrifuged and smears were prepared from drops of the cell pellets which had been resuspended in a few drops of remained serum. The slides were air-dried and stained using May-Gruenwald and Giemsa solutions. The slides were coded and analyzed "blind" in random order. The stained smears were examined using oil immersion high power magnification in regions where cells were well spread and stained. The slides were examined for the incidence of micronucleated cells per 2000 polychromatic (PCE) and 1000 normochromatic (NCE) erythrocytes per animal. The ratio of polychromatic to normochromatic erythrocytes was calculated on the basis of 1000 NCE scored.
- Statistics:
- The statistical evaluation for was performed by Global Drug Discovery Statistics using the software SAS version 9.1.3 SP4. Each of the following variables were statistical analysed:
p1 proportion of micronucleated PCE (bone marrow micronucleus assay) or micronucleated RET (peripheral blood micronucleus assay)
p2 proportion of micronucleated NCE
p3 ratio of PCE / NCE (bone marrow micronucleus assay) or % RET (peripheral blood micronucleus assay)
For investigation of treatment differences the variables p1 and p2 were arc sin ( pi ) transformed; the analyses were conducted separately for each variable. One-sided t-tests were performed to assess the difference between negative and positive controls, the latter was then excluded from further analysis. Thereafter, in an analysis of variance it was investigated whether any treatment effect was present. If a treatment effect could be shown, contrasts were used for group comparisons between each dose group and the respective vehicle control. Contrasts were analyzed on the 5 % level.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
Any other information on results incl. tables
Following treatment with 500 mg/kg BAY 74-2329, one male animal died on the second treatment day and 5 (out of 11 remaining) animals of this dose group showed adverse clinical signs, demonstrating that 500 mg/kg is the maximum tolerated dose (MTD) under these treatment conditions.
Results obtained in the Micronucleus test showed that male and female rats treated with BAY 74-2329 showed at all 3 dose levels (125, 250 and 500 mg/kg body weight) neither a biologically relevant nor statistically significant increase (p < 0.05) in micronucleated PCE and NCE as compared to the vehicle control. BAY 74-2329 induced a statistically significant decrease (p < 0.05) in the ratio of PCE to NCE in male animals, indicating that the test item reached the target cells at cytotoxic concentration. The positive control compound EMS gave the expected statistically significant (p < 0.05) increase in the micronucleated PCE and NCE cell counts as compared to the vehicle control, thus demonstrating the ability of the test system to detect cytogenetic damage.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
- Executive summary:
Evaluation of the Micronucleus test data did not show any evidence for a mutagenic potential of BAY 74-2329 in male and female rats when administered intragastrically up to the toxic dose level of 500 mg/kg bw. It is therefore concluded that BAY 74-2329 is non-mutagenic in the rat bone
marrow Micronucleus test according to OECD TG 474.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)